Cargando…

Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome

BACKGROUND: Corticosteroids are the main therapy of nephrotic syndrome and goal of corticosteroid therapy is to obtain maximum clinical benefit with minimum adverse effects. Children are more vulnerable to side effects of corticosteroids related to growth and adrenal suppression, so a search for an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singhal, Ravish, Pandit, Sadbhavna, Dhawan, Neeraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506013/ https://www.ncbi.nlm.nih.gov/pubmed/26196009 http://dx.doi.org/10.5812/ijp.510

Ejemplares similares

The Acrocallosal Syndrome in A Neonate With Further Widening of Phenotypic Expression
por: SINGHAL, Ravish, et al.
Publicado: (2014)

Deflazacort in comparison to other steroids for nephrotic syndrome
por: Jat, K. R., et al.
Publicado: (2012)

Toxic epidermal necrolysis associated with deflazacort therapy with nephrotic syndrome
por: Lee, Eun Chae, et al.
Publicado: (2014)

Klippel–Trenaunay and Sturge–Weber overlap syndrome with phakomatosis pigmentovascularis
por: Chhajed, Monika, et al.
Publicado: (2010)

Effect of prednisolone on linear growth in children with nephrotic syndrome()
por: Valavi, Ehsan, et al.
Publicado: (2018)

Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial
por: Shieh, Perry B., et al.
Publicado: (2018)

DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON
por: Nayak, Surajit, et al.
Publicado: (2008)

Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome
por: Schijvens, Anne M., et al.
Publicado: (2018)

Deflazacort-induced Acneiform Eruptions
por: Bashir, Mohammed Shakeel Mohammed, et al.
Publicado: (2017)

Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial
por: Saito, Takao, et al.
Publicado: (2013)

Retrospective cohort study comparing the efficacy of prednisolone and deflazacort in children with muscular dystrophy: A 6 years’ experience in a South Indian teaching hospital
por: Petnikota, Harish, et al.
Publicado: (2016)

A randomized study on a 3-month versus a 7-month prednisolone regimen for the initial episode of childhood idiopathic nephrotic syndrome at a large Saudi center
por: Al Talhi, AbdulHadi, et al.
Publicado: (2018)

Idiopathic nephrotic syndrome in South African children
por: Bakhiet, Yassir Mahgoub, et al.
Publicado: (2017)

Effectiveness of a Low Dose Prednisolone Regimen for Treatment of Relapses in Children with Steroid Sensitive Nephrotic Syndrome
por: Mantan, Mukta, et al.
Publicado: (2022)

Effectiveness of a Low Dose Prednisolone Regimen for Treatment of Relapses in Children with Steroid Sensitive Nephrotic Syndrome
por: Kalra, Suprita, et al.
Publicado: (2023)

Pulse Methylprednisolone with Oral Prednisolone versus Adrenocorticotropic Hormone in Children with West Syndrome: a Randomized Controlled Trial
por: Fatema, Kanij, et al.
Publicado: (2021)

Oral Dexamethasone versus Prednisolone for Management of Children with West Syndrome: An Open-Labeled Randomized Controlled Pilot Trial
por: Deswal, Monica, et al.
Publicado: (2022)

Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
por: Walter, Maggie C, et al.
Publicado: (2013)

Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
por: Parente, Luca
Publicado: (2017)

Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation
por: Webb, Nicholas J A, et al.
Publicado: (2019)

Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone
por: Fappi, Alan, et al.
Publicado: (2019)

Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy
por: Biggar, W. Douglas, et al.
Publicado: (2022)

Clinical Significance of Probiotics for Children with Idiopathic Nephrotic Syndrome
por: Yamaguchi, Tadashi, et al.
Publicado: (2021)

Single dose intravenous methyl prednisolone versus oral prednisolone in Bell's palsy: A randomized controlled trial
por: Giri, Prithvi, et al.
Publicado: (2015)

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
por: Yoshikawa, Norishige, et al.
Publicado: (2015)

A Randomized Controlled Trial of Intravenous versus Oral Cyclophosphamide in Steroid-resistant Nephrotic Syndrome in Children
por: Shah, K. M., et al.
Publicado: (2017)

Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality
por: Pasini, Andrea, et al.
Publicado: (2014)

Short Course of Daily Prednisolone During Upper Respiratory Tract Infection for Children With Relapsing Steroid Sensitive Nephrotic Syndrome
por: Mathew, Joseph L., et al.
Publicado: (2022)

Treatment of Steroid and Cyclosporine-Resistant Idiopathic Nephrotic Syndrome in Children
por: Nikibakhsh, A. A., et al.
Publicado: (2011)

Pharmacokinetics of cyclosporin - a microemulsion in children with idiopathic nephrotic syndrome
por: dos Santos Henriques, Luciana, et al.
Publicado: (2012)

An Estimation of Steroid Responsiveness of Idiopathic Nephrotic Syndrome in Iranian Children
por: Madani, Abbas, et al.
Publicado: (2010)

Occurrence of Common Allergic Diseases in Children with Idiopathic Nephrotic Syndrome
por: Wei, Chang-Ching, et al.
Publicado: (2015)

Plasma Free Homocysteine Levels in Children with Idiopathic Nephrotic Syndrome
por: Arumugam, Venkatesh, et al.
Publicado: (2019)

Are microRNA potential biomarkers in children with idiopathic nephrotic syndrome?
por: Parvex, Paloma
Publicado: (2018)

Involvement of Hemopexin in the Pathogenesis of Proteinuria in Children with Idiopathic Nephrotic Syndrome
por: Pukajło-Marczyk, Agnieszka, et al.
Publicado: (2021)

Deflazacort for the treatment of Duchenne Dystrophy: A systematic review
por: Campbell, Craig, et al.
Publicado: (2003)

Duration of initial prednisolone therapy for first episode of childhood nephrotic syndrome based on time to response
por: Tang, Xiaoshan, et al.
Publicado: (2022)

Ponticelli regimen in idiopathic nephrotic syndrome
por: Das, U., et al.
Publicado: (2009)

Extracorporeal Therapy for Idiopathic Nephrotic Syndrome
por: Au, Eric, et al.
Publicado: (2021)

Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
por: Tawalbeh, Shefa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_es89ns0k5gsvkt1tbpsujlthni